Osteopenia and vitamin D deficiency in children with sickle cell disease

European Journal of Haematology

Volumn 83, Issue 6, 2009, Pages 572-578

  Chapelon, E ^b   Garabedian, M ^c   Brousse, V ^d   Souberbielle, J C ^a   Bresson, J L ^a   De Montalembert, M ^a,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d Pediatrie Generale Hopital Necker   (France)

Author keywords

Bone mineral density; Sickle cell disease; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; HEMOGLOBIN; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN;

ABSORPTIOMETRY; ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CHILD; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SCHOOL CHILD; SECONDARY HYPERPARATHYROIDISM; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; STEADY STATE; VEIN OCCLUSION; VITAMIN D DEFICIENCY;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTHROPOMETRY; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCIUM; CALCIUM, DIETARY; CHILD; FEMALE; HOSPITALIZATION; HUMANS; LUMBAR VERTEBRAE; MALE; OSTEOCALCIN; OSTEOGENESIS; PARATHYROID HORMONE; PREVALENCE; PUBERTY; VITAMIN D DEFICIENCY;

EID: 70449487214     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01333.x     Document Type: Article

References (33)

1. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004 11 : 129 151.
2. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol 2005 129 : 482 490.
3. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 2007 92 : 905 912.
4. Neonato MG, Guilloud-Bataille M, Beauvais P, et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol 2000 65 : 155 164.
5. Nelson DA, Rizvi S, Bhattacharyya T, Ortega J, Lachant N, Swerdlow P. Trabecular and integral bone density in adults with sickle cell disease. J Clin Densitom 2003 6 : 125 129.
6. Miller RG, Segal JB, Ashar BH, Leung S, Ahmed S, Siddique S, Rice T, Lanzkron S. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol 2006 81 : 236 241.
7. Voskaridou E, Stoupa E, Antoniadou L, Premetis E, Konstantopoulos K, Papassotiriou I, Terpos E. Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis. Haematologica 2006 91 : 813 816.
8. Sadat-Ali M, Al Elq AH. Sickle cell anaemia: is it a cause for secondary osteoporosis? West Afr J Med 2007 26 : 134 137.
9. Sarrai M, Duroseau H, D'Augustine J, Moktan S, Bellevue R. Bone mass density in adults with sickle cell disease. Br J Haematol 2007 136 : 666 672.
10. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 2004 311 : 7 12.
11. Sempé M, Pédron G, Roy-Pernot M. Axologie: Méthode et Séquences. Paris : Theraplix, 1979.
12. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969 44 : 291 303.
13. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970 45 : 13 23.
14. Faulkner RA, Bailey DA, Drinkwater DT, McKay HA, Arnold C, Wilkinson AA. Bone densitometry in Canadian children 8-17 years of Age. Calcif Tissue Int 1996 59 : 344 351.
15. Brinker MR, Thomas KA, Meyers SJ, Texada T, Humbert JR, Cook SD, Gitter R. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop 1998 27 : 43 9.
16. Soliman AT, Bererhi H, Darwish A, Alzalabani MM, Wali Y, Ansari B. Decreased bone mineral density in prepubertal children with sickle cell disease: correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 1998 44 : 194 198.
17. VanderJagt DJ, Bonnett C, Okolo SN, Glew RH. Assessment of the bone status of Nigerian children and adolescents with sickle cell disease using calcaneal ultrasound and serum markers of bone metabolism. Calcif Tissue Int 2002 71 : 133 140.
18. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer 2006 47 : 901 906.
19. Buison AM, Kawchak DA, Schall JI, Ohene-Frempong K, Stallings VA, Leonard MB, Zemel BS. Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics 2005 116 : 943 949.
20. Fung EB, Kawchak DA, Zemel BS, Rovner AJ, Ohene-Frempong K, Stallings VA. Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia. Pediatr Blood Cancer 2008 50 : 620 623.
21. Adewoye AH, Chen TC, Ma Q, McMahon L, Mathieu J, Malabanan A, Steinberg MH, Holick MF. Sickle cell bone disease: response to vitamin D and calcium. Am J Hematol 2008 83 : 271 274.
22. Buison AM, Kawchak DA, Schall J, Ohene-Frempong K, Stallings VA, Zemel BS. Low vitamin D status in children with sickle cell disease. J Pediatr 2004 145 : 622 627.
23. Rovner AJ, Stallings VA, Kawchak DA, Schall JI, Ohene-Frempong K, Zemel BS. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 2008 108 : 1512 1516.
24. Williams R, George EO, Wang W. Nutrition assessment in children with SCD. J Assoc Acad Minor Phys 1997 8 : 44 8.
25. Buchowski MS, de la Fuente FA, Flakoll PJ, Chen KY, Turner EA. Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia. Am J Physiol Regul Integr Comp Physiol 2001 280 : E518 27.
26. Voskaridou E, Christoulas D, Konstantinidou M, Tsiftsakis E, Alexakos P, Terpos E. Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial. Haematologica 2008 93 : 1588 1590.
27. Azinge EC, Bolarin DM. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies. Niger J Physiol Sci 2006 21 : 21 5.
28. Soliman AT, Darwish A, Mohammed SH, Bassiony MR, el Banna N, Asfour M. Circulating growth hormone (GH), insulin-like growth factor-I (IGF-I) and free thyroxine, GH response to clonidine provocation and CT scanning of the hypothalamic-pituitary area in children with sickle cell disease. J Trop Pediatr 1995 41 : 285 289.
29. Soliman AT, el Banna N, alSalmi I, De Silva V, Craig A, Asfour M. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease. Metabolism 1997 46 : 1241 1245.
30. Soliman AT, elZalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr 1999 45 : 23 30.
31. Luporini SM, Bendit I, Manhani R, Bracco OL, Manzella L, Giannella-Neto D. Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anemia haplotypes. J Pediatr Hematol Oncol 2001 23 : 357 363.
32. Collett-Solberg PF, Fleenor D, Schultz WH, Ware RE. Short stature in children with sickle cell anemia correlates with alterations in the IGF-I axis. J Pediatr Endocrinol Metab 2007 20 : 211 218.
33. Barden EM, Zemel BS, Kawchak DA, Goran MI, Ohene-Frempong K, Stallings VA. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 2000 136 : 73 9.